APA citiranje

Gupta, A., Love, S., Schuh, A., Shanyinde, M., Larkin, J., Plummer, R., . . . Middleton, M. (2014). DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma. Oxford University Press.

Chicago Style (17th ed.) Citation

Gupta, A., et al. DOC-MEK: A Double-blind Randomized Phase II Trial of Docetaxel with or Without Selumetinib in Wild-type BRAF Advanced Melanoma. Oxford University Press, 2014.

MLA citiranje

Gupta, A., et al. DOC-MEK: A Double-blind Randomized Phase II Trial of Docetaxel with or Without Selumetinib in Wild-type BRAF Advanced Melanoma. Oxford University Press, 2014.